The Constitutional Court of Kenya has blocked the government from implementing that country's Anti-Counterfeiting Act as it applies to generic medicines. The law has been challenged as unconstitutional on the grounds that it endangers lives by arbitrarily denying access to affordable generic medications.
Kenya Constitutional Court Blocks Anti-Counterfeiting Law
April 23, 2010
Share this post
One Comment

Law Bytes
Ep. 265 – Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
byMichael Geist

Ep. 265 – Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
April 20, 2026
Michael Geist
March 30, 2026
Michael Geist
March 16, 2026
Michael Geist
Search Results placeholder
Michael Geist on Substack
Recent Posts
Is Data De-Identification Dead?: Why the AI Privacy Risk Isn’t What It Learns, But What It Figures Out
The Law Bytes Podcast, Episode 265: Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
A Standard That Doesn’t Exist: Parliamentary Secretary for Justice Offers Misleading Defence of Bill C-22’s Lower Threshold for Subscriber Information
More Surveillance Demands to Come?: Government Admits Bill C-22’s Lawful Access Provisions Could Be Expanded
Win, Lose or Draw?: The Federal Court of Appeal Overrules a Key Copyright Case on Procedural Grounds

A good point made by the criticism of the anti-counterfeiting act in Kenya was that it conflated the quality-control aspects of anti-counterfeiting laws with copyright/patent/trademark issues. Most rhetoric I’ve seen connected with ACTA makes the same mistake, whether deliberately or not.